Gozewijn D. Laverman
University Medical Center Groningen
108 Papers
489 Citations
Gozewijn D. Laverman is an academic researcher from University Medical Center Groningen. The author has contributed to research in topics: Medicine & Renal function. The author has an hindex of 20, co-authored 71 publications.
Chat about Author
Papers
Fibroblast Growth Factor 23 and Adverse Clinical Outcomes in Type 2 Diabetes: a Bitter-Sweet Symphony
TL;DR: It is suggested that FGF23 are elevated and may also be a risk factor for cardiovascular disease and mortality in type 2 diabetes patients without CKD, although the magnitude of the association is smaller than in CKD patients.
Sex differences in renin-angiotensin-aldosterone system affect extracellular volume in healthy subjects.
Tsjitske J. Toering,Christina M. Gant,Folkert W. Visser,Anne Marijn van der Graaf,Gozewijn D. Laverman,A.H. Jan Danser,Marijke M. Faas,Gerjan Navis,A. Titia Lely +8 more
TL;DR: Constitutive sex differences in the regulation of aldosterone, characterized by a higher ald testosterone and a lower adrenal response to exogenous angiotensin II infusion in men, are associated with a higher extracellular volume and blood pressure in men.
Integrated Assessment of Pharmacological and Nutritional Cardiovascular Risk Management: Blood Pressure Control in the DIAbetes and LifEstyle Cohort Twente (DIALECT)
Christina M. Gant,S Heleen Binnenmars,Else van den Berg,Stephan J. L. Bakker,Gerjan Navis,Gozewijn D. Laverman +5 more
TL;DR: The data show a window of opportunity for improving BP control, especially in nutritional management, and advocate to incorporate the integrated monitoring of nutritional management in quality improvement cycles in routine care.
Distal renal tubular acidosis with multiorgan autoimmunity: A case report
Maria J. van den Wildenberg,Ewout J. Hoorn,Nilufar Mohebbi,Carsten A. Wagner,Arend-Jan Woittiez,Peter Alexander Marcel de Vries,Gozewijn D. Laverman +6 more
TL;DR: This case demonstrates that in patients with dRTA without a classic autoimmune disorder, autoimmunity may still be the underlying cause, and circulating autoantibodies against intercalated cells have yet to be determined.
Dual blockade of the renin-angiotensin-aldosterone system in cardiac and renal disease
TL;DR: Long-term randomized studies are needed to support the benefits of dual blockade for long-term renal and cardiovascular outcome in CKD and whether dual blockade has better efficacy and/or fewer adverse effects than optimized monotherapy has not been investigated.